Safety and efficacy of turoctocog alfa (NovoEight®) - during surgery in patients with haemophilia A: results from the multinational guardian™ clinical trials.2015 Jan;21(1):34-40.

Results

Naziv:	Safety and efficacy of turoctocog alfa (NovoEight®) - during surgery in patients with haemophilia A: results from the multinational guardian™ clinical trials.2015 Jan;21(1):34-40.
Autori:	Santagostino, E.; Lentz, S. R.; Misgav, M.; Brand, B.; Chowdary, P.; Savić, Aleksandar ; Kilinc, Y.; Amit, Y.; Amendola, A.; Solimeno, L. P.; Saugstrup, T.; Matytsina, I.;
Godina:	2014
Publikacija:	Haemophilia
ISSN:	1351-8216 Haemophilia Pretraži identifikator
Tip rezultata:	Naučni članak
Kolacija:	vol. 21 br. 1 str. 34-40
DOI:	10.1111/hae.12518
WoS-ID:	000346985600033
Scopus-ID:	2-s2.0-84921509343
PMID:	25273984
PMCID:	PMC4309503
URI:	https://enauka.gov.rs/handle/123456789/169080
Izvor metapodataka:	Migrirano iz RIS podataka
M-kategorija:	22M22 - Međunarodni časopis kategorije M22

46
SCOPUS^TM

27
PubMed Central^TM

25
OpenCitations

46
WEB OF SCIENCE^TM

Altmetric

Dimensions

Unpaywall